Relmada Therapeutics, Inc. focuses on developing various products for the treatment of central nervous system diseases and other disorders.The company was founded in 2004 and is headquartered in Coral Gables, Florida. Its lead product candidate is Esmethadone, a new chemical entity and N-methyl-D-aspartate receptor antagonist.
